SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001062993-08-000042
Filing Date
2008-01-07
Accepted
2008-01-07 16:03:07
Documents
1
Period of Report
2007-11-27
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO CURRENT REPORT form8ka.htm 8-K/A 288502
  Complete submission text file 0001062993-08-000042.txt   290396
Mailing Address SUITE 3.19 MLS BUSINESS CENTRE 130 SHAFTESBURY AVENUE LONDON X0 W1D 5EU
Business Address SUITE 3.19 MLS BUSINESS CENTRE 130 SHAFTESBURY AVENUE LONDON X0 W1D 5EU 44(0)20 7031-1189
NEXTGEN BIOSCIENCE INC. (Filer) CIK: 0001343465 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 000-51935 | Film No.: 08515219
SIC: 3577 Computer Peripheral Equipment, NEC
Assistant Director 3